✦Canada Post Xpress1–2 day delivery across CanadaFree on orders over $200
Your cart is empty
Melanocortin Receptor Research Peptide — Nasal Spray
Melanotan II is a synthetic cyclic peptide analogue derived from alpha-melanocyte–stimulating hormone (α-MSH). It is developed for controlled laboratory research involving melanocortin receptor signaling systems.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Melanotan II is a synthetic cyclic peptide analogue derived from alpha-melanocyte–stimulating hormone (α-MSH). It is developed for controlled laboratory research involving melanocortin receptor signaling systems.
In scientific literature, Melanotan II is studied in experimental models examining melanocortin receptor interaction, neuroendocrine signaling pathways, and receptor-mediated regulatory mechanisms under in vitro and preclinical research conditions.
Melanotan II is a cyclic melanocortin receptor agonist evaluated in research focused on melanocortin pathway signaling and receptor interaction dynamics. Experimental studies examine its interaction within neuroendocrine regulatory systems and melanocortin-associated signaling frameworks under controlled laboratory conditions.
Research publications have explored its receptor-binding profile and pathway-level signaling characteristics within structured experimental environments.
Melanotan II originated from research into melanocortin receptor agonists derived from α-MSH analogues. Structural modifications led to the development of cyclic peptides designed to enhance receptor interaction properties for experimental study.
Subsequent investigations documented its receptor subtype interaction and signaling behavior in laboratory research models.
Laboratory investigations into Melanotan II have focused on melanocortin receptor activation models and neuroendocrine signaling pathways. Research frameworks evaluate receptor-mediated interaction, melanocortin pathway dynamics, and peptide-associated regulatory systems under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 10mg of lyophilized Melanotan II. Independent third-party testing verifies purity, identity, and net content per batch.
The vial contains only the peptide preparation. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Therapeutic Strategies Against Metabolic Imbalance in a Male Mouse Model With 5-HT2CR Loss-of-Function.
PubMed5-Hydroxypyrroloindoline Affords Tryptathionine and 2,2′-bis-Indole Peptide Staples: Application to Melanotan-II.
PubMedMelanotan-II reverses memory impairment induced by a short-term HF diet.
PubMedMelanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for food.
PubMedTargeting Melanocortin Receptors Using SNAr-Type Macrocyclization: A Doubly Orthogonal Route to Cyclic Peptide Conjugates.
PubMedRelated
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$70.00
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$50.00
Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$60.00
GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$90.00
